ANISH KOKA
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease PHILADELPHIA, PA NPI 1740236124
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease PA Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$37,289.91
- Category: General Payments
- Program years: PY2018–2024
- Record count: 463
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,299.80 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,299.80 | 52 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $322.20 | 7 |
| Acerta Pharma LLC | $147.14 | 7 |
| Amgen Inc. | $123.09 | 5 |
| Novo Nordisk AS | $100.16 | 5 |
| Actelion Pharmaceuticals US, Inc. | $94.22 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $91.35 | 3 |
| Alnylam Pharmaceuticals Inc. | $69.36 | 3 |
| Abbott Laboratories | $62.35 | 3 |
| E.R. Squibb & Sons, L.L.C. | $45.55 | 3 |
| PFIZER INC. | $32.51 | 2 |
| Kiniksa Pharmaceuticals International, plc | $30.82 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $29.11 | 1 |
| HEARTFLOW, INC. | $24.77 | 1 |
| Merck Sharp & Dohme Corporation | $21.57 | 1 |
| GlaxoSmithKline, LLC. | $20.57 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.25 | 1 |
| Esperion Therapeutics, Inc. | $17.98 | 1 |
| Philips Electronics North America Corporation | $17.83 | 1 |
| iRhythm Technologies, Inc. | $15.03 | 1 |
| GENZYME CORPORATION | $13.94 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.